• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.

作者信息

Bardazzi Federico, Loi Camilla, Sacchelli Lidia, Di Altobrando Ambra

机构信息

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

出版信息

J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6.

DOI:10.1080/09546634.2020.1749545
PMID:32248724
Abstract
摘要

相似文献

1
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.在新冠疫情期间，银屑病的生物治疗并非一种选择。
J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6.
2
Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.2019冠状病毒病疫情期间银屑病的生物治疗：选择需权衡风险与获益。
Dermatol Ther. 2020 Jul;33(4):e13490. doi: 10.1111/dth.13490. Epub 2020 May 20.
3
COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.新型冠状病毒肺炎、梅毒与银屑病及银屑病关节炎的生物治疗：一则警示
J Am Acad Dermatol. 2020 Jun;82(6):e213. doi: 10.1016/j.jaad.2020.03.079. Epub 2020 Apr 1.
4
A challenging case of psoriasis flare-up after COVID-19 infection.1例新型冠状病毒肺炎感染后银屑病病情加重的疑难病例。
J Dermatolog Treat. 2020 Aug;31(5):448-449. doi: 10.1080/09546634.2020.1764904. Epub 2020 May 15.
5
Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution".回复：“2019冠状病毒病、梅毒与银屑病和银屑病关节炎的生物疗法：一则警示”
J Am Acad Dermatol. 2020 Jun;82(6):e215. doi: 10.1016/j.jaad.2020.03.103. Epub 2020 Apr 10.
6
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
7
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
8
COVID-19 and immunomodulator/immunosuppressant use in dermatology.新型冠状病毒肺炎与皮肤科中免疫调节剂/免疫抑制剂的应用
J Am Acad Dermatol. 2020 May;82(5):e173-e175. doi: 10.1016/j.jaad.2020.03.046. Epub 2020 Mar 26.
9
Reply: "Biologics for psoriasis during COVID-19 outbreak".回复：“新冠疫情期间用于银屑病的生物制剂”
J Am Acad Dermatol. 2020 Jun;82(6):e217-e218. doi: 10.1016/j.jaad.2020.04.004. Epub 2020 Apr 10.
10
Should patients stop their biologic treatment during the COVID-19 pandemic.在新冠疫情期间，患者是否应该停止生物制剂治疗？
J Dermatolog Treat. 2020 Jun;31(4):317-318. doi: 10.1080/09546634.2020.1742438. Epub 2020 Mar 19.

引用本文的文献

1
The Relationship Between Psoriasis, COVID-19 Infection and Vaccination During Treatment of Patients.银屑病、COVID-19 感染与治疗期间疫苗接种的关系。
Adv Exp Med Biol. 2023;1412:339-355. doi: 10.1007/978-3-031-28012-2_18.
2
COVID-19 Knowledge in Patients with Psoriasis Receiving Systemic Therapy: a Questionnaire Study.接受全身治疗的银屑病患者的新冠病毒知识：一项问卷调查研究。
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022166. doi: 10.5826/dpc.1204a166. eCollection 2022 Nov.
3
Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
2019年冠状病毒病大流行对慢性炎症性免疫介导性皮肤病病程及管理的影响：有哪些证据？
Clin Dermatol. 2021 Jan-Feb;39(1):52-55. doi: 10.1016/j.clindermatol.2020.12.012. Epub 2020 Dec 15.
4
Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital.新冠疫情期间的银屑病护理：来自德国一家大学附属医院的治疗和预约变化的真实世界数据。
Eur J Dermatol. 2021 Apr 1;31(2):183-191. doi: 10.1684/ejd.2021.4016.
5
The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul.COVID-19 对银屑病患者的影响：伊斯坦布尔的一项多中心研究。
Dermatol Ther. 2021 Jan;34(1):e14691. doi: 10.1111/dth.14691. Epub 2020 Dec 30.
6
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy.意大利新冠疫情期间慢性斑块状银屑病生物疗法的管理
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e770-e772. doi: 10.1111/jdv.16841. Epub 2020 Aug 10.
7
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.COVID-19 大流行中的皮肤表现和注意事项：系统评价。
Dermatol Ther. 2020 Nov;33(6):e13986. doi: 10.1111/dth.13986. Epub 2020 Aug 6.
8
Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.银屑病、新冠病毒肺炎与急性呼吸窘迫综合征：关注联合生物治疗的风险
Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19.
9
COVID-19 and dermatology: a comprehensive guide for dermatologists.新型冠状病毒肺炎与皮肤病学：皮肤科医生实用指南。
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1388-1394. doi: 10.1111/jdv.16545. Epub 2020 Jun 10.
10
Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.2019冠状病毒病疫情期间银屑病的生物治疗：选择需权衡风险与获益。
Dermatol Ther. 2020 Jul;33(4):e13490. doi: 10.1111/dth.13490. Epub 2020 May 20.